59469-305 NDC - DALEKTRO N (SILVER NITRATE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, COBALTOUS NITRATE HEXAHYDRATE, CUPRIC ACETATE, IRON, POTASSIUM CARBONATE, MAGNESIUM CHLORIDE, MANGANESE ACETATE TETRAHYDRATE, SELENIUM, SILICON DIOXIDE, AND ZINC PHOSPHIDE)

Drug Information

  • Product NDC: 59469-305
  • Proprietary Name: DALEKTRO N
  • Non Proprietary Name: SILVER NITRATE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, COBALTOUS NITRATE HEXAHYDRATE, CUPRIC ACETATE, IRON, POTASSIUM CARBONATE, MAGNESIUM CHLORIDE, MANGANESE ACETATE TETRAHYDRATE, SELENIUM, SILICON DIOXIDE, and ZINC PHOSPHIDE
  • Active Ingredient(s): 6 [hp_X]/100mL COBALTOUS NITRATE HEXAHYDRATE; 12 [hp_X]/100mL CUPRIC ACETATE; 6 [hp_X]/100mL IRON; 4 [hp_X]/100mL MAGNESIUM CHLORIDE; 8 [hp_X]/100mL MANGANESE ACETATE TETRAHYDRATE; 6 [hp_X]/100mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 4 [hp_X]/100mL POTASSIUM CARBONATE; 12 [hp_X]/100mL SELENIUM; 12 [hp_X]/100mL SILICON DIOXIDE; 6 [hp_X]/100mL SILVER NITRATE; 12 [hp_X]/100mL ZINC PHOSPHIDE
  • Administration Route(s): ORAL
  • Dosage Form(s): SOLUTION/ DROPS
  • Pharmacy Class(es): Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name Field Value
Labeler Name: PEKANA Natruheilmittel GmbH
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:6/24/2019

Package Information

No. Package Code Package Description Billing Unit
159469-305-101 BOTTLE, GLASS in 1 BOX (59469-305-10) / 50 mL in 1 BOTTLE, GLASS
259469-305-401 BOTTLE, GLASS in 1 BOX (59469-305-40) / 100 mL in 1 BOTTLE, GLASS

NDC Record

Field Name Field Value Definition
PRODUCT NDC59469-305The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEDALEKTRO NThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMESILVER NITRATE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, COBALTOUS NITRATE HEXAHYDRATE, CUPRIC ACETATE, IRON, POTASSIUM CARBONATE, MAGNESIUM CHLORIDE, MANGANESE ACETATE TETRAHYDRATE, SELENIUM, SILICON DIOXIDE, and ZINC PHOSPHIDEThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/24/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEPEKANA Natruheilmittel GmbHName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECOBALTOUS NITRATE HEXAHYDRATE; CUPRIC ACETATE; IRON; MAGNESIUM CHLORIDE; MANGANESE ACETATE TETRAHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; SELENIUM; SILICON DIOXIDE; SILVER NITRATE; ZINC PHOSPHIDEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 12; 6; 4; 8; 6; 4; 12; 12; 6; 12 
ACTIVE INGRED UNIT[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL 
PHARM CLASSESCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code